These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 34850616)

  • 1. Comparative study of human growth hormone measurements: impact on clinical interpretation.
    Lotierzo M; Olaru-Soare F; Dupuy AM; Plawecki M; Paris F; Cristol JP
    Clin Chem Lab Med; 2022 Jan; 60(2):191-197. PubMed ID: 34850616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Performance evaluation of a fully automated immunoassay for the detection of human growth hormone on the Elecsys immunoassay system.
    Van Helden J; Hermsen D; Von Ahsen N; Bidlingmaier M
    Clin Lab; 2014; 60(10):1641-51. PubMed ID: 25651709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Harmonization of growth hormone measurements with different immunoassays by data adjustment.
    Müller A; Scholz M; Blankenstein O; Binder G; Pfäffle R; Körner A; Kiess W; Heider A; Bidlingmaier M; Thiery J; Kratzsch J
    Clin Chem Lab Med; 2011 Jul; 49(7):1135-42. PubMed ID: 21627539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical evidence-based cutoff limits for GH stimulation tests in children with a backup of results with reference to mass spectrometry.
    Wagner IV; Paetzold C; Gausche R; Vogel M; Koerner A; Thiery J; Arsene CG; Henrion A; Guettler B; Keller E; Kiess W; Pfaeffle R; Kratzsch J
    Eur J Endocrinol; 2014 Sep; 171(3):389-97. PubMed ID: 24966174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Performance Evaluation of the Elecsys Growth Hormone and Insulin-Like Growth Factor 1 Assay.
    Kim SK; Jeong TD
    Clin Lab; 2020 Jul; 66(7):. PubMed ID: 32658425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and Psychometric Evaluation of the Life Interference Questionnaire for Growth Hormone Deficiency (LIQ-GHD) to Assess Growth Hormone Injection Burden in Children and Adults.
    Turner-Bowker DM; Yaworsky A; Palladino A; Lamoureux RE; Kelly M; Love E; Pleil AM; Shields A; Loftus J
    Patient; 2020 Jun; 13(3):289-306. PubMed ID: 31956960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Registration system for growth hormone (GH) treatment with standardized immunoreactive GH values in Japan.
    Tanaka T; Takano K; Hanew K; Nishi Y; Igarashi Y; Hirano T; Saito T; Tachibana K; Yokoya S; Fujieda K; Shimatsu A; Hizuka N; Tsushima T; Irie M
    Endocr J; 1998 Aug; 45(4):459-65. PubMed ID: 9881894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunofunctional assay of human growth hormone (hGH) in serum: a possible consensus for quantitative hGH measurement.
    Strasburger CJ; Wu Z; Pflaum CD; Dressendörfer RA
    J Clin Endocrinol Metab; 1996 Jul; 81(7):2613-20. PubMed ID: 8675586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The growth hormone cascade: progress and long-term results of growth hormone treatment in growth hormone deficiency.
    Grumbach MM; Bin-Abbas BS; Kaplan SL
    Horm Res; 1998; 49 Suppl 2():41-57. PubMed ID: 9730672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specific monoclonal antibodies and ultrasensitive immunoassays for 20K and 22K human growth hormone.
    Wu Z; Devany E; Balarini G; Junnila R; Bidlingmaier M; Strasburger CJ
    Growth Horm IGF Res; 2010 Jun; 20(3):239-44. PubMed ID: 20304691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-equivalence of anti-Müllerian hormone automated assays-clinical implications for use as a companion diagnostic for individualised gonadotrophin dosing.
    Iliodromiti S; Salje B; Dewailly D; Fairburn C; Fanchin R; Fleming R; Li HWR; Lukaszuk K; Ng EHY; Pigny P; Tadros T; van Helden J; Weiskirchen R; Nelson SM
    Hum Reprod; 2017 Aug; 32(8):1710-1715. PubMed ID: 28854583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Growth hormone isoforms in acromegalic patients before and after treatment with octreotide LAR.
    Lima GA; Wu Z; Silva CM; Barbosa FR; Dias JS; Schrank Y; Strasburger CJ; Gadelha MR
    Growth Horm IGF Res; 2010 Apr; 20(2):87-92. PubMed ID: 19884028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum 25-hydroxyvitamin D measurement: Comparative evaluation of three automated immunoassays.
    Trimboli F; Rotundo S; Armili S; Mimmi S; Lucia F; Montenegro N; Antico GC; Cerra A; Gaetano M; Galato F; Giaquinto Carinci L; Iania D; Mancuso S; Martucci M; Teti C; Greco M; Cuda G; Angotti E
    Pract Lab Med; 2021 Aug; 26():e00251. PubMed ID: 34386568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anthropometric factors have significant influence on the outcome of the GHRH-arginine test: establishment of normative data for an automated immunoassay specifically measuring 22 kDa human growth hormone.
    Deutschbein T; Bidlingmaier M; Schopohl J; Strasburger CJ; Petersenn S
    Eur J Endocrinol; 2017 Mar; 176(3):273-281. PubMed ID: 27932410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-Acting C-Terminal Peptide-Modified hGH (MOD-4023): Results of a Safety and Dose-Finding Study in GHD Children.
    Zelinska N; Iotova V; Skorodok J; Malievsky O; Peterkova V; Samsonova L; Rosenfeld RG; Zadik Z; Jaron-Mendelson M; Koren R; Amitzi L; Raduk D; Hershkovitz O; Hart G
    J Clin Endocrinol Metab; 2017 May; 102(5):1578-1587. PubMed ID: 28323965
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overweight/Obese adults with pituitary disorders require lower peak growth hormone cutoff values on glucagon stimulation testing to avoid overdiagnosis of growth hormone deficiency.
    Dichtel LE; Yuen KC; Bredella MA; Gerweck AV; Russell BM; Riccio AD; Gurel MH; Sluss PM; Biller BM; Miller KK
    J Clin Endocrinol Metab; 2014 Dec; 99(12):4712-9. PubMed ID: 25210883
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of a new automated immunoassay for the quantification of anti-Müllerian hormone.
    Lotierzo M; Urbain V; Dupuy AM; Cristol JP
    Pract Lab Med; 2021 May; 25():e00220. PubMed ID: 34095410
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Growth hormone (GH) pharmacogenetics: influence of GH receptor exon 3 retention or deletion on first-year growth response and final height in patients with severe GH deficiency.
    Jorge AA; Marchisotti FG; Montenegro LR; Carvalho LR; Mendonca BB; Arnhold IJ
    J Clin Endocrinol Metab; 2006 Mar; 91(3):1076-80. PubMed ID: 16291702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GH deficiency status combined with GH receptor polymorphism affects response to GH in children.
    Valsesia A; Chatelain P; Stevens A; Peterkova VA; Belgorosky A; Maghnie M; Antoniazzi F; Koledova E; Wojcik J; Farmer P; Destenaves B; Clayton P;
    Eur J Endocrinol; 2015 Dec; 173(6):777-89. PubMed ID: 26340968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of urinary human growth hormone (hGH) using hydrogel nanoparticles and isoform differential immunoassays after short recombinant hGH treatment: preliminary results.
    Bosch J; Luchini A; Pichini S; Tamburro D; Fredolini C; Liotta L; Petricoin E; Pacifici R; Facchiano F; Segura J; Garaci E; Gutiérrez-Gallego R
    J Pharm Biomed Anal; 2013 Nov; 85():194-7. PubMed ID: 23954438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.